U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07315945) titled 'Implementation of an Allergic Rhinitis Severity Questionnaire in ENT Consultations' on Dec. 18, 2025.
Brief Summary: Allergic rhinitis is a very common condition (affecting 1 in 5 people in Europe) and a costly one for society (direct and indirect costs). Symptoms vary depending on the time of year, and treatments are primarily symptomatic, with follow-up in ENT consultations. Scientific societies (EAACI, FDA, EMA) recommend using a universal tool (severity score) (the CSMS score, SCST in French) to monitor severity and follow-up, and to obtain consistent data that can be extrapolated to other scientific data (meta-analyses).
Theref...